MedPath

SPECTRUMCEUTICALS PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

31

TGA:31

Drug Approvals

L Reuteri Oral Powder (489282)

Product Name
L Reuteri Oral Powder
Approval Date
May 20, 2025
TGA

ProBiosis (488907)

Product Name
ProBiosis
Approval Date
May 15, 2025
TGA

Bifido Complex (466050)

Product Name
Bifido Complex
Approval Date
Oct 28, 2024
TGA

Pro8-50 Plus (465226)

Product Name
Pro8-50 Plus
Approval Date
Oct 22, 2024
TGA

IBS Support (465227)

Product Name
IBS Support
Approval Date
Oct 22, 2024
TGA

Infant and Child Flora (445395)

Product Name
Infant and Child Flora
Approval Date
Apr 5, 2024
TGA

Pro8-Forte (444359)

Product Name
Pro8-Forte
Approval Date
Mar 25, 2024
TGA

Pro4-50 hard capsules (444357)

Product Name
Pro4-50 hard capsules
Approval Date
Mar 25, 2024
TGA

ProBiosis (444358)

Product Name
ProBiosis
Approval Date
Mar 25, 2024
TGA

ProBioFlora Reuteri (436491)

Product Name
ProBioFlora Reuteri
Approval Date
Jan 22, 2024
TGA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.